Gut,
a leading international journal from BMJ and BSG, publishes cutting-edge gastroenterology and hepatology research and reviews
Impact Factor: 24.5
Citescore: 47.4
All metrics >>
Visual Abstracts
Visual Abstracts provide summaries of the latest research in a single, visual format.
View our latest visual abstract below. See a high-resolution version of the Visual Abstract and read the full article.
Gut Commentary Series on Digestive Health and Climate Change
We are delighted to introduce to the Gut readership a compendium of nine commentaries, each summarising one, or a hybrid, of the nine educational webinars organised by the World Gastroenterology Organisation.
Latest Articles
Letter:
Microscopic pathology assessment of colorectal polyp size is less accurate than intracolonoscopic assessment28 March 2024
Letter:
Re-evaluating early-onset OSCC in Africa: findings of minimal cumulative incidence26 March 2024
Recent advances in clinical practice:
Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers25 March 2024
Most Read Articles
Recent advances in clinical practice:
Updates to the modern diagnosis of GERD: Lyon consensus 2.05 January 2024
Guideline:
British Society of Gastroenterology guidelines on sedation in gastrointestinal endoscopy5 January 2024
Irritable bowel syndrome:
Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trial23 February 2024
Gut microbiota:
Prebiotic diet changes neural correlates of food decision-making in overweight adults: a randomised controlled within-subject cross-over trial5 January 2024
Gut immunity:
Dietary wheat amylase trypsin inhibitors exacerbate CNS inflammation in experimental multiple sclerosis7 December 2023
Altmetrics
Podcasts
Featured Video
Specific gut pathobionts escape antibody coating and are enriched during flares in patients with severe Crohn’s disease
Conclusion Distinct gut bacterial IgG2-coating was demonstrated in patients with severe CD and during disease flares. Co-occurrence of non-coated pathobionts with IgG2-coated bacteria points to an uncontrolled inflammatory condition in severe CD mediated via escape from antibody coating by two gut pathobionts.
Find out more